R. Vanholder, Z. Massy, and A. Argiles, Chronic kidney disease as cause of cardiovascular morbidity and mortality, Nephrology Dialysis Transplantation, vol.20, issue.6, pp.1048-1056, 2005.
DOI : 10.1046/j.1523-1755.2003.00924.x

R. Vanholder, D. Smet, R. Glorieux, and G. , Review on uremic toxins: Classification, concentration, and interindividual variability, Kidney International, vol.63, issue.5, pp.1934-1943, 2003.
DOI : 10.1046/j.1523-1755.2003.00924.x

URL : https://doi.org/10.1046/j.1523-1755.2003.00924.x

F. Barreto, D. Barreto, and S. Liabeuf, Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients, Clinical Journal of the American Society of Nephrology, vol.4, issue.10, pp.1551-1558, 2009.
DOI : 10.2215/CJN.03980609

L. Dou, M. Sallee, and C. Cerini, The Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid, Journal of the American Society of Nephrology, vol.26, issue.4, pp.876-887, 2015.
DOI : 10.1681/ASN.2013121283

URL : https://hal.archives-ouvertes.fr/hal-01610425

C. Lin, V. Wu, and P. Wu, Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure, PLOS ONE, vol.45, issue.Suppl 1, p.132589, 2015.
DOI : 10.1371/journal.pone.0132589.s001

K. Kerr, A. Meisner, and H. Thiessen-philbrook, Developing Risk Prediction Models for Kidney Injury and Assessing Incremental Value for Novel Biomarkers, Clinical Journal of the American Society of Nephrology, vol.9, issue.8, pp.1488-1496, 2014.
DOI : 10.2215/CJN.10351013

URL : http://cjasn.asnjournals.org/content/9/8/1488.full.pdf

H. Schwarzenbach, N. Nishida, and G. Calin, Clinical relevance of circulating cell-free microRNAs in cancer, Nature Reviews Clinical Oncology, vol.20, issue.3, pp.145-156, 2014.
DOI : 10.1245/s10434-013-3093-4

N. Chen, K. Kiattisunthorn, O. Neill, and K. , Decreased MicroRNA Is Involved in the Vascular Remodeling Abnormalities in Chronic Kidney Disease (CKD), PLoS ONE, vol.26, issue.5, p.64558, 2013.
DOI : 10.1371/journal.pone.0064558.t002

F. Taibi, V. Metzinger-le-meuth, M. Baya-moutoula, and E. , Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1842, issue.1, pp.88-98, 2014.
DOI : 10.1016/j.bbadis.2013.10.005

A. Rangrez, M. Baya-moutoula, E. , M. Meuth, and V. , Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223, PLoS ONE, vol.7, issue.10, p.47807, 2012.
DOI : 10.1371/journal.pone.0047807.s009

T. Harris, M. Yamakuchi, and M. Ferlito, MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1, Proceedings of the National Academy of Sciences, vol.115, issue.2, pp.1516-1521, 2008.
DOI : 10.1016/S0092-8674(03)00803-1

K. Cordes, N. Sheehy, and M. White, miR-145 and miR-143 regulate smooth muscle cell fate and plasticity, Nature, vol.106, pp.705-710, 2009.
DOI : 10.1016/S0002-9440(10)64465-3

URL : http://europepmc.org/articles/pmc2769203?pdf=render

M. Baya-moutoula, E. Louvet, L. , M. Meuth, and V. , High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1852, issue.10, pp.2202-2212, 2015.
DOI : 10.1016/j.bbadis.2015.08.003

C. Neal, M. Michael, and L. Pimlott, Circulating microRNA expression is reduced in chronic kidney disease, Nephrology Dialysis Transplantation, vol.13, issue.11, pp.3794-3802, 2011.
DOI : 10.1038/ncb2210

URL : https://academic.oup.com/ndt/article-pdf/26/11/3794/17108195/gfr485.pdf

M. Xiang, Y. Zeng, and R. Yang, U6 is not a suitable endogenous control for the quantification of circulating microRNAs, Biochemical and Biophysical Research Communications, vol.454, issue.1, pp.210-214, 2014.
DOI : 10.1016/j.bbrc.2014.10.064

T. Roberts, A. Coenen-stass, and M. Wood, Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum, PLoS ONE, vol.57, issue.2, p.89237, 2014.
DOI : 10.1371/journal.pone.0089237.s007

M. Santos, A. Metzinger, L. Haddad, and O. , miR- 126 is involved in vascular remodeling under laminar shear stress, Biomed Res Int, vol.2015, p.497280, 2015.

S. Fichtlscherer, A. Zeiher, and S. Dimmeler, Circulating MicroRNAs: Biomarkers or Mediators of Cardiovascular Diseases?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.31, issue.11, pp.2383-2390, 2011.
DOI : 10.1161/ATVBAHA.111.226696

R. Calaf, C. Cerini, and C. Genovesio, Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay, Journal of Chromatography B, vol.879, issue.23, pp.2281-2286, 2011.
DOI : 10.1016/j.jchromb.2011.06.014

URL : https://hal.archives-ouvertes.fr/hal-01460285

A. Rangrez, Z. Massy, M. Meuth, and V. , miR-143 and miR-145: Molecular Keys to Switch the Phenotype of Vascular Smooth Muscle Cells, Circulation: Cardiovascular Genetics, vol.4, issue.2, pp.197-205, 2011.
DOI : 10.1161/CIRCGENETICS.110.958702

G. Pontoriero, M. Cozzolino, and F. Locatelli, CKD Patients: The Dilemma of Serum PTH Levels, Nephron Clinical Practice, vol.116, issue.4, pp.263-268, 2010.
DOI : 10.1159/000318787

K. I. Nikolov, I. Mozar, A. Drueke, and T. , Impact of Disturbances of Calcium and Phosphate Metabolism on Vascular Calcification and Clinical Outcomes in Patients with Chronic Kidney Disease, Blood Purification, vol.27, issue.4, pp.350-359, 2009.
DOI : 10.1159/000209248

M. Sarnak and R. Foley, Cardiovascular Mortality in the General Population Versus Dialysis: A Glass Half Full or Empty?, American Journal of Kidney Diseases, vol.58, issue.1, pp.4-6, 2011.
DOI : 10.1053/j.ajkd.2011.04.004

L. Elia, M. Quintavalle, and J. Zhang, The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease, Cell Death & Differentiation, vol.1, issue.12, pp.1590-1598, 2009.
DOI : 10.1038/nrcardio.2009.56

F. Martino, J. Lorenzen, and J. Schmidt, Circulating MicroRNAs Are Not Eliminated by Hemodialysis, PLoS ONE, vol.26, issue.11, p.38269, 2012.
DOI : 10.1371/journal.pone.0038269.t001

URL : https://doi.org/10.1371/journal.pone.0038269

G. Becker and T. Hewitson, Animal models of chronic kidney disease: useful but not perfect, Nephrology Dialysis Transplantation, vol.31, issue.2, pp.2432-2438, 2013.
DOI : 10.1152/physiolgenomics.00069.2007

A. Leelahavanichkul, Q. Yan, and X. Hu, Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model, Kidney International, vol.78, issue.11, pp.1136-1153, 2010.
DOI : 10.1038/ki.2010.287

W. Zhang, L. Shi, and H. Zhang, Effect of alprostadil on serum level of miRNA-155 in uremic patients], Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol.40, pp.735-741, 2015.

S. Wang, A. Aurora, and B. Johnson, The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis, Developmental Cell, vol.15, issue.2, pp.261-271, 2008.
DOI : 10.1016/j.devcel.2008.07.002

URL : https://doi.org/10.1016/j.devcel.2008.07.002

Y. Vengrenyuk, H. Nishi, and X. Long, Cholesterol Loading Reprograms the MicroRNA-143/145???Myocardin Axis to Convert Aortic Smooth Muscle Cells to a Dysfunctional Macrophage-Like PhenotypeSignificance, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.3, pp.535-546, 2015.
DOI : 10.1161/ATVBAHA.114.304029

Y. Wei, M. Zhu, and J. Corbalan-campos, in Macrophages Mediates the Stage-Specific Effects of MicroRNA-155 on AtherosclerosisSignificance, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.4, pp.796-803, 2015.
DOI : 10.1161/ATVBAHA.114.304723

P. Gross, Z. Massy, and L. Henaut, Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling, Journal of Cellular Physiology, vol.2000, issue.12, pp.2927-2935, 2015.
DOI : 10.1093/ndt/gfr453

I. Six, P. Gross, and M. Remond, Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120, Atherosclerosis, vol.243, issue.1, pp.248-256, 2015.
DOI : 10.1016/j.atherosclerosis.2015.09.019

I. Igaz, G. Nyiro, and Z. Nagy, following Administration of Dexamethasone and Adrenocorticotropin, International Journal of Endocrinology, vol.2015, p.589230, 2015.
DOI : 10.1016/j.ecl.2013.10.005

URL : http://doi.org/10.1155/2015/589230

S. Liabeuf, L. Desjardins, and Z. Massy, Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes, Circulation Journal, vol.80, issue.3, pp.722-730, 2016.
DOI : 10.1253/circj.CJ-15-0949